-
1
-
-
0017362711
-
Diabetes: The quest for basal normoglycaemia
-
Holman RR, Turner RC: Diabetes: The quest for basal normoglycaemia. The Lancet I: 469-474, 1977
-
(1977)
The Lancet
, vol.1
, pp. 469-474
-
-
Holman, R.R.1
Turner, R.C.2
-
2
-
-
0019416827
-
The basal plasma glucose: A simple relevant index of maturity-onset diabetes
-
Holman RR, Turner RC: The basal plasma glucose: A simple relevant index of maturity-onset diabetes. Clin Endocrinol 14: 279-286, 1980
-
(1980)
Clin Endocrinol
, vol.14
, pp. 279-286
-
-
Holman, R.R.1
Turner, R.C.2
-
3
-
-
0020456354
-
Evidence that peak II GLI or enteroglucagon is identical to the C-terminal sequence (residues 33-69) of glicentin
-
Holst JJ: Evidence that peak II GLI or enteroglucagon is identical to the C-terminal sequence (residues 33-69) of glicentin. Biochem J 207: 381-388, 1982
-
(1982)
Biochem J
, vol.207
, pp. 381-388
-
-
Holst, J.J.1
-
4
-
-
0026502473
-
Effects of a combination of bedtime intermediate-acting insulin and glibenclamide in Type II (non-insulin-dependent) diabetic patients with secondary failure to respond to oral hypoglycaemic agents
-
Krempf M, Godeau T, Ranganathan S, Blanchard P, Ritz R, Chabonnel B: Effects of a combination of bedtime intermediate-acting insulin and glibenclamide in Type II (non-insulin-dependent) diabetic patients with secondary failure to respond to oral hypoglycaemic agents. Eur J Clin Pharmacol 42: 281-286, 1992
-
(1992)
Eur J Clin Pharmacol
, vol.42
, pp. 281-286
-
-
Krempf, M.1
Godeau, T.2
Ranganathan, S.3
Blanchard, P.4
Ritz, R.5
Chabonnel, B.6
-
5
-
-
0023638829
-
Glucagon-like peptide 1 (7-36): A physiological incretin in man
-
Kreymann B, Ghatei MA, Williams G, Bloom SR: Glucagon-like peptide 1 (7-36): a physiological incretin in man. Lancet II: 1300-1304, 1987
-
(1987)
Lancet
, vol.2
, pp. 1300-1304
-
-
Kreymann, B.1
Ghatei, M.A.2
Williams, G.3
Bloom, S.R.4
-
6
-
-
0026542396
-
Insulinotropic action of glucagon-like peptide-I-(7-37) in diabetic and nondiabetic subjects
-
Nathan DM, Schreiber E, Fogel H, Mojsov S, Habener JF: Insulinotropic action of glucagon-like peptide-I-(7-37) in diabetic and nondiabetic subjects. Diabetes Care 15: 270-276, 1992
-
(1992)
Diabetes Care
, vol.15
, pp. 270-276
-
-
Nathan, D.M.1
Schreiber, E.2
Fogel, H.3
Mojsov, S.4
Habener, J.F.5
-
7
-
-
0027419106
-
Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 (7-36 amide) infused at near-physiological insulinotropic hormone and glucose concentrations
-
Nauck M, Bartels E, Ørskov C, Ebert R, Creutzfeldt W: Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 (7-36 amide) infused at near-physiological insulinotropic hormone and glucose concentrations. J Clin Endocrinol Metab 76: 912-917, 1993a
-
(1993)
J Clin Endocrinol Metab
, vol.76
, pp. 912-917
-
-
Nauck, M.1
Bartels, E.2
Ørskov, C.3
Ebert, R.4
Creutzfeldt, W.5
-
8
-
-
7144250388
-
Inhibition of gastric emptying by GLP-1 (7-36 amide) or (7-37): Effects on postprandial glycaemia and insulin secretion
-
Nauck MA, Ettler R, Niedereichholz U, Ørskov C, Holst JJ, Schmiegel W: Inhibition of gastric emptying by GLP-1 (7-36 amide) or (7-37): Effects on postprandial glycaemia and insulin secretion (abstract). Gut 37 (Suppl. 2): A 124, 1995
-
(1995)
Gut
, vol.37
, Issue.2 SUPPL.
-
-
Nauck, M.A.1
Ettler, R.2
Niedereichholz, U.3
Ørskov, C.4
Holst, J.J.5
Schmiegel, W.6
-
9
-
-
0027391607
-
Preserved incretin activity of glucagon-like peptide 1 (GLP-1) (7-36 amide) but not of synthetic human gastric inhibitory polypeptide (GIP) in patients with NIDDM mellitus
-
Nauck MA, Heimesaat MM, Ørskov C, Holst JJ, Ebert R, Creutzfeldt W: Preserved incretin activity of glucagon-like peptide 1 (GLP-1) (7-36 amide) but not of synthetic human gastric inhibitory polypeptide (GIP) in patients with NIDDM mellitus. J Clin Invest 91: 301-307, 1993b
-
(1993)
J Clin Invest
, vol.91
, pp. 301-307
-
-
Nauck, M.A.1
Heimesaat, M.M.2
Ørskov, C.3
Holst, J.J.4
Ebert, R.5
Creutzfeldt, W.6
-
10
-
-
0027248866
-
Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients
-
Nauck MA, Kleine N, Ørskov C, Holst JJ, Willms B, Creutzfeldt W: Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36: 741-744, 1993c
-
(1993)
Diabetologia
, vol.36
, pp. 741-744
-
-
Nauck, M.A.1
Kleine, N.2
Ørskov, C.3
Holst, J.J.4
Willms, B.5
Creutzfeldt, W.6
-
11
-
-
0026659679
-
Glucagon-like peptide-1, a new hormone of the entero-insular axis
-
Ørskov C: Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia 35: 701-711, 1992
-
(1992)
Diabetologia
, vol.35
, pp. 701-711
-
-
Ørskov, C.1
-
12
-
-
0023104848
-
Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2)
-
Ørskov C, Holst JJ: Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2). Scand J Clin Lab Invest 47: 165-174, 1987
-
(1987)
Scand J Clin Lab Invest
, vol.47
, pp. 165-174
-
-
Ørskov, C.1
Holst, J.J.2
-
13
-
-
0028281773
-
Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide 1 in humans
-
Ørskov C, Rabenhøj L, Wettergren A., Kofod H, Holst JJ: Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide 1 in humans. Diabetes 43: 535-539, 1994
-
(1994)
Diabetes
, vol.43
, pp. 535-539
-
-
Ørskov, C.1
Rabenhøj, L.2
Wettergren, A.3
Kofod, H.4
Holst, J.J.5
-
14
-
-
0028904931
-
Insulinotropic actions of intravenous glucagon-like peptide-1 (GLP-1) (7-36 amide) in the fasting state in healthy subjects
-
Qualmann, C, Nauck MA, Holst JJ, Ørskov C, W Creutzfeldt. Insulinotropic actions of intravenous glucagon-like peptide-1 (GLP-1) (7-36 amide) in the fasting state in healthy subjects. Acta Diabetol 32: 13-16, 1995
-
(1995)
Acta Diabetol
, vol.32
, pp. 13-16
-
-
Qualmann, C.1
Nauck, M.A.2
Holst, J.J.3
Ørskov, C.4
Creutzfeldt, W.5
-
15
-
-
0031033531
-
Near-normalization of diurnal glucose concentrations by continous administration of glucagon-like peptide 1 (GLP-1) in subjects with NIDDM
-
Rachman J, Barrow BA, Levy JC, Turner RC: Near-normalization of diurnal glucose concentrations by continous administration of glucagon-like peptide 1 (GLP-1) in subjects with NIDDM. Diabetologia 40: 205-211, 1997
-
(1997)
Diabetologia
, vol.40
, pp. 205-211
-
-
Rachman, J.1
Barrow, B.A.2
Levy, J.C.3
Turner, R.C.4
-
16
-
-
0029909112
-
Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM
-
Rachman J, Gribble FM, Barrow BA, Levy JC, Buchanan KD, Turner RC: Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM. Diabetes 45: 1524-1530, 1996
-
(1996)
Diabetes
, vol.45
, pp. 1524-1530
-
-
Rachman, J.1
Gribble, F.M.2
Barrow, B.A.3
Levy, J.C.4
Buchanan, K.D.5
Turner, R.C.6
-
17
-
-
0021959922
-
New tactics for type II diabetes: Regimens based on intermediate-acting insulin taken at bedtime
-
Riddle MC: New tactics for type II diabetes: regimens based on intermediate-acting insulin taken at bedtime. Lancet 1: 192-195, 1985
-
(1985)
Lancet
, vol.1
, pp. 192-195
-
-
Riddle, M.C.1
-
18
-
-
0024432987
-
Efficacy of bedtime NPH insulin with daytime sulfonylurea for a subpopulation of Type II diabetes
-
Riddle MC, Hart JS, Bouma DJ, Philipson BE, Youker G: Efficacy of bedtime NPH insulin with daytime sulfonylurea for a subpopulation of Type II diabetes. Diabetes Care 12: 623-629, 1989
-
(1989)
Diabetes Care
, vol.12
, pp. 623-629
-
-
Riddle, M.C.1
Hart, J.S.2
Bouma, D.J.3
Philipson, B.E.4
Youker, G.5
-
19
-
-
0028959214
-
Bedtime insulin/ daytime glipizide: Effective therapy for sulfonylurea failures in NIDDM
-
Shank ML, Del Prato S, De Fronzo RA. Bedtime insulin/ daytime glipizide: Effective therapy for sulfonylurea failures in NIDDM. Diabetes 44: 165-172, 1995
-
(1995)
Diabetes
, vol.44
, pp. 165-172
-
-
Shank, M.L.1
Del Prato, S.2
De Fronzo, R.A.3
-
20
-
-
0024396718
-
Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide
-
Trischitta V, Italia S, Borzi V, Tribualto A, Mazzarino S, Squatrito S, Vigneri R: Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide. Diabetes Care 12: 582-585, 1989
-
(1989)
Diabetes Care
, vol.12
, pp. 582-585
-
-
Trischitta, V.1
Italia, S.2
Borzi, V.3
Tribualto, A.4
Mazzarino, S.5
Squatrito, S.6
Vigneri, R.7
-
21
-
-
3543143570
-
Prolonged normalization of fasting hyperglycaemia by intravenous GLP-1 ((7-36 amide) or (7-37)) in NIDDM patients
-
Weber I, Bach-Esser, A-K, Bach I, Richter S, Orskov C, Holst JJ, Schmiegel W, Nauck MA: Prolonged normalization of fasting hyperglycaemia by intravenous GLP-1 ((7-36 amide) or (7-37)) in NIDDM patients (abstract). Diabetologia 38 (Suppl. 1): A 171, 1995
-
(1995)
Diabetologia
, vol.38
, Issue.1 SUPPL.
-
-
Weber, I.1
Bach-Esser, A.-K.2
Bach, I.3
Richter, S.4
Orskov, C.5
Holst, J.J.6
Schmiegel, W.7
Nauck, M.A.8
-
22
-
-
0027533758
-
Truncated GLP-1 (proglucagon 87-107-amide) inhibits gastric and pancreatic functions in man
-
Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ: Truncated GLP-1 (proglucagon 87-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 38: 665-673, 1993
-
(1993)
Dig Dis Sci
, vol.38
, pp. 665-673
-
-
Wettergren, A.1
Schjoldager, B.2
Mortensen, P.E.3
Myhre, J.4
Christiansen, J.5
Holst, J.J.6
-
23
-
-
7144256360
-
Overnight GLP-1 (7-36 amide), daytime oral agents: Failure to lower postprandial glucose by normalizing fasting values in NIDDM patients
-
Willms B, Idowu K, Holst JJ, Nauck MA: Overnight GLP-1 (7-36 amide), daytime oral agents: Failure to lower postprandial glucose by normalizing fasting values in NIDDM patients. Diabetes 45 (Suppl. 2): 301A, 1996a
-
(1996)
Diabetes
, vol.45
, Issue.2 SUPPL.
-
-
Willms, B.1
Idowu, K.2
Holst, J.J.3
Nauck, M.A.4
-
24
-
-
0030068620
-
Gastric emptying, glucose responses and insulin secretion after a liquid test meal: Effects of exogenous glucagon-like peptide 1 (GLP-1) (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients
-
Willms B, Werner J, Holst JJ, Ørskov C, Creutzfeldt W, Nauck MA: Gastric emptying, glucose responses and insulin secretion after a liquid test meal: Effects of exogenous glucagon-like peptide 1 (GLP-1) (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients. J Clin Endocrinol Metab 81: 327-332, 1996b
-
(1996)
J Clin Endocrinol Metab
, vol.81
, pp. 327-332
-
-
Willms, B.1
Werner, J.2
Holst, J.J.3
Ørskov, C.4
Creutzfeldt, W.5
Nauck, M.A.6
-
25
-
-
0026468324
-
Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus
-
Yki-Järvinen H, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Niskanen L, Rajala S, Ryysy L, Salo S, Seppälä P, Tulokas T, Viikari J, Karjalainen J, Taskinen M-R: Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 327: 1426-1433, 1992
-
(1992)
N Engl J Med
, vol.327
, pp. 1426-1433
-
-
Yki-Järvinen, H.1
Kauppila, M.2
Kujansuu, E.3
Lahti, J.4
Marjanen, T.5
Niskanen, L.6
Rajala, S.7
Ryysy, L.8
Salo, S.9
Seppälä, P.10
Tulokas, T.11
Viikari, J.12
Karjalainen, J.13
Taskinen, M.-R.14
|